
Patients with asthma appeared overexposed to oral corticosteroids, potentially putting them at risk for long-term side effects, according to a study published in The Journal of Allergy and Clinical Immunology: In Practice.
New protocols and better education could reduce these risks and improve care, Akke-Nynke van der Meer, MD, pulmonologist in the department of medicine at Medical Centre Leeuwarden in the Netherlands, and colleagues wrote.
Further, the researchers noted growing evidence of the risks for cumulative lifetime exposure to oral corticosteroids (OCS) and the potential benefits of